cookie image

Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. Cookies are small text files that are placed on your computer or mobile phone when you browse websites.

LEARN MORE >

Cookies help us:

  • Make our website work as you’d expect.
  • Provide a message we believe is more relevant to you.

We do not use cookies to:

  • Collect any personally identifiable information.
  • Collect any sensitive information.
  • Pass personally identifiable data to third parties.

You can learn more about all the cookies and the information we collect by reading our Privacy Policy. If you don’t want to use cookies you can either exit the website or change your browser settings.

close
Skip to main content
Back to News Articles

Answers to patients’ top 5 questions on All of Us Research Program

American Medical Association Wire

With the goal of enrolling 1 million or more participants, the All of Us Research Program is among the most ambitious data-gathering efforts in medical history. Unlike a single research study focused on a specific disease or population, All of Us will serve as a national research resource, covering a wide variety of health conditions.

Participants in the program—which is open to the healthy and the sick—will contribute to an effort to advance the health of generations to come. The success of All of Us requires informed patients and health care providers. To that end, the AMA and NIH have worked in tandem to help you answer these top five questions that patients are likely to have about participating in this emerging initiative.

What is precision medicine?

Precision medicine is an innovative approach to disease prevention and treatment that takes into account individual differences in people’s environments, lifestyles and genes. Precision medicine gives clinicians resources to get a more well-rounded picture of a person’s health and can help inform decisions on prevention strategies and treatments that may be the safest and most effective.

READ THE FULL ARTICLE